The CDKN1C gene helps put the brakes on cell growth, especially before birth and in early childhood. In medicine, this gene is important because it helps regulate how quickly tissues grow and when cells should stop dividing. If the CDKN1C gene does not work properly, growth may become too fast or too limited, depending on the variant. Reduced activity of the CDKN1C gene is linked to Beckwith-Wiedemann syndrome, while increased activity can be linked to IMAGe syndrome.
What is a gene?
Genes are stretches of DNA that provide cells with instructions to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, which are the cell’s working parts. Others mainly direct when certain processes take place, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
CDKN1CGene function
What if the gene works
The CDKN1C gene helps keep cell growth under control. It acts like a brake on cell division, which supports normal growth and development, especially before birth.
Risk
What if the gene does not work
Changes in the CDKN1C gene can upset growth control. Milder to more severe variants may cause overgrowth with Beckwith-Wiedemann syndrome or, in other cases, growth restriction with IMAGe syndrome, affecting how early features appear and how marked they are.
Treatment
What does that mean for your treatment
There is no CDKN1C-directed drug therapy, but current Beckwith-Wiedemann spectrum guidelines may use a pathogenic variant in the CDKN1C gene to help tailor management, especially tumor surveillance, because overall tumor risk is often lower than in some other molecular subtypes. Treatment otherwise remains based on the person's features rather than a special medicine choice.
Conditions associated with CDKN1C
Gene function
What if the gene works
Cell growth needs careful timing. The CDKN1C gene helps keep that timing under control by telling some cells when to pause before dividing. This is a key part of how the CDKN1C gene helps control cell growth and supports normal development, especially before birth.
Inside your cells, the CDKN1C gene makes a protein that slows the push to divide. This helps keep new cell production measured rather than constant.
One of its main roles is to help cells pause at the right point before copying themselves. This gives growth signals a chance to be checked so division stays coordinated.
This gene also helps some cells step out of the division cycle as they take on more specialized jobs. That supports the orderly building of tissues during development.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not cause any noticeable effect and are simply part of natural genetic diversity. In some cases, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants in the CDKN1C gene affect growth depends on the DNA change. Some reduce how much protein is made or leave it shortened or unstable, while others make it too active for longer. Milder weakening variants may leave some braking effect, but more severe ones can remove most of it and are often linked to earlier, more marked overgrowth when the maternal copy is affected. Variants that make the protein too active can over restrain growth and underlie IMAGe syndrome.
How variants are linked to conditions
Variants in the CDKN1C gene are mainly linked to two inherited growth conditions: Beckwith-Wiedemann syndrome and IMAGe syndrome. When a pathogenic variant affects the active maternal copy, it can cause one of these diagnoses, with Beckwith-Wiedemann syndrome tending to involve overgrowth and IMAGe syndrome tending to involve poor growth before and after birth. These are the best-established conditions linked to CDKN1C gene variants.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CDKN1C, risk is mainly shaped by the specific gene change and whether it comes from the mother, because the mother's copy is usually the one that is active. Family history can raise the chance of carrying the same change. Lifestyle factors are not known to meaningfully change this genetic risk.
Inheritance of CDKN1C variants
The inheritance pattern for CDKN1C-related conditions depends on the specific condition and which parent passed on the variant. In Beckwith-Wiedemann syndrome and IMAGe syndrome, CDKN1C variants are typically inherited in an autosomal dominant way, but usually cause health effects only when the altered copy is inherited from the mother because the paternal copy is usually switched off in most tissues. This parent-of-origin effect is an important part of how a CDKN1C gene variant is inherited in families. Some cases can also result from a new variant that was not inherited from either parent.
What does my CDKN1C result mean for my family?
For CDKN1C, family meaning depends on which side of the family the changed gene came from. This gene is mainly active when inherited from the mother, so close relatives on the mother’s side may be more likely to have the same result or related health features, while a change passed on from the father may have little or no effect. Because of this parent-of-origin pattern, relatives may have very different chances of being affected even within the same family.
Genetic information
Genetic testing
How you find out about variants
CDKN1C genetic testing usually uses a blood or saliva sample to look for variants in the CDKN1C gene. Genetic testing for CDKN1C variants often uses DNA sequencing, which reads the gene’s code, and the result is interpreted with family history because the mother’s copy is usually the one most linked to health effects.
When should I consider getting a genetic test?
Genetic testing for the CDKN1C gene may be considered when a child has signs of a growth condition, such as being unusually large, repeated low blood sugar, or one side of the body growing more than the other. It can also help when a child is unusually small with ongoing growth and hormone problems, or when these conditions run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug. These differences are common and can influence both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how differences in genes affect the way people respond to medications. It studies gene drug patterns to help explain why the same treatment can work differently in different people. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CDKN1C gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
The CDKN1C gene entered genetics through research on chromosome 11p15, a region linked to unusual growth patterns in children. In the 1990s, scientists identified CDKN1C, also called p57KIP2, and recognized that it is subject to genomic imprinting, meaning mainly the copy from the mother is active. This finding helped clarify why some inherited changes in the same region could lead to different conditions. Building on this early work, scientists connected changes in the CDKN1C gene to Beckwith-Wiedemann syndrome and later to IMAGe syndrome, showing how one gene could be involved in both overgrowth and restricted growth. Over time, descriptions became more precise. These discoveries made CDKN1C an important part of the history of growth genetics.